You have 9 free searches left this month | for more free features.

Condition

Allergic Rhinoconjunctivitis (1)

Asthma (1)

Atopic Dermatitis (1)

Grass Pollen Allergy (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

phase 2 (2)

Sponsor

LEO Pharma (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Regeneron Pharmaceuticals (1)

Collaborator

ALK-Abello A/S (1)

Immune Tolerance Network (ITN) (1)

PPD (1)

Regeneron Pharmaceuticals (1)

Rho Federal Systems Division, Inc. (1)

Sanofi (1)

Intervention

dupixent® (3)

dupixent® placebo (1)

grazax® (1)

grazax® placebo (1)

leo 138559 (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (2)

NIH (1)

Study Type

Interventional (2)

Observational [Patient Registry] (1)

dupixent®

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Atopic Dermatitis Trial in Wien (LEO 138559, Dupixent®)

Recruiting

Atopic Dermatitis

LEO 138559
Dupixent®

Wien, Austria

LEO Investigational Site

Jul 21, 2022

Allergic Rhinoconjunctivitis, Grass Pollen Allergy Trial in London (Dupixent®, Grazax®, Dupixent® Placebo)

Recruiting

Allergic Rhinoconjunctivitis
Grass Pollen Allergy

Dupixent®
+3 more

London, United Kingdom

Royal Brompton Hospital

Jul 5, 2022

Asthma Trial in Worldwide (DUPIXENT®)

Recruiting

Asthma

DUPIXENT®

Birmingham, Alabama
+123 more

Jan 13, 2023